Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth

Date: May 22, 2010
Pages: 107
Price:
US$ 3,835.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B6E5DB5F91EEN
Leaflet:

Download PDF Leaflet

Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth
The pharmaceutical industry is challenged with information integration and mapping across the various business processes. This information challenge, along with other issues such as weak product development pipelines, growing generics competition, and rising R&D and regulatory compliance costs are compelling pharmaceutical companies to look for alternatives to remain competitive, maintain profit margins, and enhance market share. Implementation of Business Intelligence (BI) enables the business processes to access more accurate and real-time information, with an ultimate goal of increased efficiency and reduced corporate costs.

This report provides an overview of the BI market in the pharmaceutical sector, including its size and growth, followed by the current trends of BI technologies and adoption of BI tools across key pharmaceutical processes. It gives an insight into the various key players in the BI market, analyzing them based on their product offerings and growth strategies. In addition to the BI supply side, this report assesses the state of the BI market from the demand side perspective. Demand side analysis investigates the uptake of BI in the pharmaceutical sector, investments in current BI use, and planned future use.

Key features of this report
  • Analysis of the BI market in the pharmaceutical sector in terms of size and growth rate.
  • Evaluation of the drivers behind the increased spending on BI solutions by Big Pharma companies.
  • Key challenges in developing a data warehouse that delivers BI capabilities for the pharmaceutical industry.
  • Demand side analysis of the uptake of BI in the pharmaceutical sector, investment in current BI use, and planned future use.
  • Insight into the activities, views, and strategies of the major BI vendors.
Scope of this report
  • Understand the BI needs across major pharmaceutical industry processes and the benefits that entail from BI implementation.
  • Understand the uptake of BI in the pharmaceutical sector by organization size and by geographic location.
  • Identify the organizational priorities of life science companies and how BI can improve the quality of decision making.
  • Benchmark your performance against the major BI vendors based on knowledge of their product offerings and growth strategies.
Key Market Issues
  • The data intensive nature of the pharmaceutical industry makes BI deployment more challenging than other industries.
  • Data availability at different time periods, frequent changes in the legislation, and growing consolidation in the pharmaceutical industry makes the BI adoption process particularly challenging.
  • Reduction of knowledge process service costs is a pressing priority for most pharmaceutical companies.
  • BI vendors need to work with the pharmaceutical companies to identify areas or patterns where the costs can be reduced and educate the pharmaceutical companies about the advantages of moving towards adopting easy to use and prepackaged pharma-specific BI solutions.
Key findings from this report
  • The BI market in the pharmaceutical industry was worth around $495m in 2009, and is forecast to grow to $555m by 2012.
  • Besides achieving operational excellence, pharmaceutical companies are investing in BI implementation in technical areas, such as to improving research and clinical performance, resource management, sales force tracking and regulatory compliance reporting.
  • Business Insights’ survey of the pharmaceutical sector found that 67% of the respondents currently use BI tools.
  • Of current users, 71% have indicated that launching new products and services in existing markets is likely to influence their decision over whether to increasingly use BI tools and services in 2010–11.
  • Approximately 49% of respondents confirmed their intention to reduce SG&A costs in 2010–11.
Key questions answered
  • What is the market size and growth rate over the period 2006-2012 for BI spending in pharmaceutical sector?
  • What are the major drivers for increased BI adoption in the pharmaceutical sector?
  • What are the key challenges that make BI adoption difficult for the industry?
  • What does the current BI vendor landscape look like?
  • How will the emerging advanced analytics capabilities and industry/process-specific offerings determine which vendors remain dominant in the future?
Business Intelligence in the Pharmaceutical Market
Executive summary
The Business Intelligence market in the pharmaceutical sector
Key processes in the pharmaceutical sector
The uptake of Business Intelligence in the pharmaceutical sector
The demand side of Business Intelligence in the pharmaceutical sector
The Business Intelligence vendor landscape
The future of the Business Intelligence market in the pharmaceutical sector

CHAPTER 1 INTRODUCTION

Introduction
Who is this report for?
Research methodology

CHAPTER 2 THE BUSINESS INTELLIGENCE MARKET IN THE PHARMACEUTICAL SECTOR

Summary
Introduction
Importance of BI in the pharmaceutical industry
BI market in the pharmaceutical industry: size and growth
Drivers for BI adoption in the pharmaceutical industry
Enabling strategic decision making
Enabling identification of latest sales forecasts and trends
Increased outsourcing
Attaining cost efficiency
Challenges for implementing BI in the pharmaceutical industry
Current BI trends in the pharmaceutical industry
BI moving beyond operational excellence to technical areas
Customized service offering by BI vendors

CHAPTER 3 KEY PROCESSES IN THE PHARMACEUTICAL SECTOR

Summary
Introduction
Pharmaceutical processes
Drug discovery
Drug development
Manufacturing and supply chain
Sales and marketing

CHAPTER 4 THE UPTAKE OF BUSINESS INTELLIGENCE IN THE PHARMACEUTICAL SECTOR

Summary
Introduction
Business Intelligence uptake
Current BI usage
Uptake by organization size
Uptake by geographies
Short-term BI drivers among current users
Longer-term BI drivers among current users
BI usage forecast
BI usage forecast by components
BI usage forecast by enterprise functions
Planned increases in spending on Business Intelligence
Plans to increase usage: case for persuasion

CHAPTER 5 THE DEMAND SIDE OF BUSINESS INTELLIGENCE IN THE PHARMACEUTICAL SECTOR

Summary
Introduction
Organizational priorities
Cost reduction: which areas to target?
Reducing SG&A costs
Cost reduction priorities
Business Intelligence users – case studies
GlaxoSmithKline – management of the clinical trial process and enhancement of drug development
Wyeth Pharma – managing sales effectiveness

CHAPTER 6 THE BUSINESS INTELLIGENCE VENDOR LANDSCAPE

Summary
Introduction
The mega vendors
IBM Business Intelligence: Cognos, SPSS, ILOG, and IBM BAO
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
Microsoft Business Intelligence
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
Oracle
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
SAP BusinessObjects
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
Niche vendors
Actuate
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
Information Builders
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
MicroStrategy
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
QlikTech
Company overview
Key offerings and verticals
Pharmaceutical solution and major customers
Competitors
Growth strategies
SAS
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies
TIBCO Spotfire
Company overview
Key offerings and verticals
Pharmaceutical solutions and major customers
Competitors
Growth strategies

CHAPTER 7 THE FUTURE OF THE BUSINESS INTELLIGENCE MARKET IN THE PHARMACEUTICAL SECTOR

Summary
Introduction
Transition of the pharmaceutical sales and marketing model through predictive analytics
Major vendors
Shifting to in-memory analytics helps rapid information delivery to the sales force
Major vendors
Leveraging SaaS for data analytics
Major vendors
Open source paving its way into SMBs
Major vendors
Appendix
Glossary
Index

LIST OF FIGURES

Figure 2.1: BI spending by big pharma in the US and Europe ($m), 2006–2012
Figure 2.2: Drivers and challenges for BI implementation in the pharmaceutical industry
Figure 2.3: Current BI trends in the pharmaceutical industry
Figure 3.4: Pharma-specific typical Business Intelligence solutions
Figure 4.5: BI usage by organizations (% respondents, 2010)
Figure 4.6: Current BI users by areas of operation (% respondents using BI, 2010)
Figure 4.7: BI users by organization size (% respondents, 2010)
Figure 4.8: BI users by geography (% respondents, 2010)
Figure 4.9: Short-term factors most likely to drive BI uptake among current users
Figure 4.10: Longer-term factors likely to drive BI uptake among current users (% respondents)
Figure 4.11: Forecast of BI usage by components (% respondents)
Figure 4.12: Forecast of BI usage by enterprise functions (% respondents)
Figure 4.13: Current user plans to change spending on BI in 2010–2011
Figure 4.14: Case for persuasion: current BI user indecisiveness by enterprise functions
Figure 5.15: Organizational priorities
Figure 5.16: Is reduction of SG&A costs a high priority in 2010?
Figure 5.17: Cost reduction priorities by enterprise function
Figure 6.18: Business Intelligence vendor landscape
Figure 6.19: Summary of the mega vendors
Figure 7.20: Spectrum of Business Intelligence technologies

LIST OF TABLES

Table 3.1: Drug discovery KPIs and BI solutions
Table 3.2: Drug development KPIs and BI solutions
Table 3.3: Manufacturing and supply chain KPIs and BI solutions
Table 3.4: Sales and marketing KPIs and BI solutions
Table 6.5: IBM Cognos Business Intelligence offerings
Table 6.6: IBM Cognos pharmaceutical solutions
Table 6.7: IBM major M&A deals, 2008–2010*
Table 6.8: Microsoft Business Intelligence offerings
Table 6.9: Microsoft Business Intelligence pharmaceutical solutions
Table 6.10: Microsoft Business Intelligence major M&A deals, 2008–2010*
Table 6.11: Oracle Business Intelligence offerings
Table 6.12: Oracle pharmaceutical solutions
Table 6.13: Oracle major M&A deals, 2008–10*
Table 6.14: SAP BusinessObjects Business Intelligence offerings
Table 6.15: SAP BusinessObjects pharmaceutical solutions
Table 6.16: SAP BusinessObjects major M&A deals, 2008–2010*
Table 6.17: Actuate Business Intelligence offerings
Table 6.18: Actuate pharmaceutical solutions
Table 6.19: Actuate major M&A deal, 2008–2010*
Table 6.20: Information Builders’ Business Intelligence offerings
Table 6.21: Information Builders’ pharmaceutical solutions
Table 6.22: MicroStrategy Business Intelligence offerings
Table 6.23: MicroStrategy pharmaceutical solutions
Table 6.24: QlikTech pharmaceutical solutions
Table 6.25: SAS Business Intelligence offerings
Table 6.26: SAS pharmaceutical solutions
Table 6.27: SAS major M&A deals, 2008–2010*
Table 6.28: TIBCO Spotfire Business Intelligence offerings
Table 6.29: TIBCO Spotfire pharmaceutical solutions
Table 6.30: TIBCO Spotfire major M&A deal, 2008–2010*
Skip to top


Ask Your Question

Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: